ADHD. Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
Intervention 1: Control group: According to the patient's condition, the dose of Ritalin is 0.1 to 3.5 mg per kilogram of body weight + placebo daily for 8 weeks. Intervention 2: Intervention group: A
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 11 Years
Inclusion criteria
Inclusion criteria: Age between 6-11 years Diagnosis of ADHD based on DSM5
Exclusion criteria
Exclusion criteria: Age range outside 6-11 years Diagnosis of a serious disease, or disease requiring surgery, or neurological diseases Diagnosis of a psychiatric disorder and taking neuropsychiatric drugs, except for ADD History of treatment with sulforaphane in the last three months History of treatment with neuroleptic medication in the last six months Weight less than 13.5 kg Mental retardation Seizure A systolic blood pressure greater than 125 or a resting heart rate less than 60 or greater than 115 History of allergy to sulforaphane or methylphenidate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of ADHD. Timepoint: Weeks: 0 , 4 , 8. Method of measurement: By ADHD Rating Scale (by parents or teacher). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shahin Akhondzadeh
Tehran University of Medical Sciences
Outcome results
None listed